Cargando…

Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation

Solid organ transplantation (SOT) is the best treatment option for end-stage organ disease. Newer immunosuppressive agents have reduced the incidence of graft rejection but have increased the risk of infection, particularly due to the reactivation of latent infections due to opportunistic agents suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Jose Tiago, San-Juan, Rafael, Fernández-Ruiz, Mario, Aguado, José María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639553/ https://www.ncbi.nlm.nih.gov/pubmed/31341356 http://dx.doi.org/10.3748/wjg.v25.i26.3291

Ejemplares similares

Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection
por: Pais, João Pedro, et al.
Publicado: (2022)

Prevalence of latent Mycobacterium tuberculosis infection in renal transplant recipients
por: Maciel, Mônica Maria Moreira Delgado, et al.
Publicado: (2018)

Prevalence of latent Mycobacterium tuberculosis infection in prisoners
por: de Navarro, Pedro Daibert, et al.
Publicado: (2016)

Evaluation of latent tuberculosis infection in liver transplant recipients
por: Ahmadinejad, Zahra, et al.
Publicado: (2021)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011)

Behçet’s disease with latent Mycobacterium tuberculosis infection
por: Shen, Yan, et al.
Publicado: (2020)

Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
por: Mayito, Jonathan, et al.
Publicado: (2019)

Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models
por: Villate, José I, et al.
Publicado: (2006)

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
por: Karampela, Irene, et al.
Publicado: (2020)

The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis
por: Castro, Rhastin A D, et al.
Publicado: (2020)

Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection
por: Ahmad, Suhail
Publicado: (2011)

Latent tuberculosis infection and kidney transplantation
por: Tuon, Felipe Francisco
Publicado: (2021)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
por: Samuel, Didier, et al.
Publicado: (2018)

What Do We Really Know about How CD4 T Cells Control Mycobacterium tuberculosis?
por: Torrado, Egidio, et al.
Publicado: (2011)

The growing need to monitor the liver function after SARS-CoV-2 infection in the Mexican population with obesity
por: Rivera-Valdes, Juan José, et al.
Publicado: (2022)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
por: Pérez-Lago, Laura, et al.
Publicado: (2015)

Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection
por: Schuck, Sebastian D., et al.
Publicado: (2009)

Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling
por: Halliday, Alice, et al.
Publicado: (2017)

Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection
por: Maekura, Ryoji, et al.
Publicado: (2019)

Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children
por: Druszczynska, Magdalena, et al.
Publicado: (2021)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Differential levels of anti-Mycobacterium tuberculosis-specific IgAs in saliva of household contacts with latent tuberculosis infection
por: Ruiz-Tagle, Cinthya, et al.
Publicado: (2023)

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
por: Getahun, Haileyesus, et al.
Publicado: (2015)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
por: Sayadi, Mahdieh, et al.
Publicado: (2020)

Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection
por: Zhang, Caiqin, et al.
Publicado: (2014)

An Overview of Genetic Information of Latent Mycobacterium tuberculosis
por: Hamidieh, Faezeh, et al.
Publicado: (2021)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
por: Liang, Yan, et al.
Publicado: (2023)

ORFeome-based identification of biomarkers for serodiagnosis of Mycobacterium tuberculosis latent infection
por: Zhou, Fangbin, et al.
Publicado: (2017)

Mycobacterium tuberculosis progresses through two phases of latent infection in humans
por: Colangeli, Roberto, et al.
Publicado: (2020)

Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy
por: Baker, Jacob J., et al.
Publicado: (2023)

Diagnostic Potential of the Serological Response to Synthetic Peptides from Mycobacterium tuberculosis Antigens for Discrimination Between Active and Latent Tuberculosis Infections
por: Araujo, Zaida, et al.
Publicado: (2022)

High-Resolution Melting Analysis for the Rapid Detection of Fluoroquinolone and Streptomycin Resistance in Mycobacterium tuberculosis
por: Lee, Ann S. G., et al.
Publicado: (2012)

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis
por: Coeck, Nele, et al.
Publicado: (2016)

Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations
por: Rigouts, L., et al.
Publicado: (2019)

Inclusion of minor alleles improves catalogue-based prediction of fluoroquinolone resistance in Mycobacterium tuberculosis
por: Brankin, Alice E, et al.
Publicado: (2023)

Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020)

Transcription of Genes Involved in Sulfolipid and Polyacyltrehalose Biosynthesis of Mycobacterium tuberculosis in Experimental Latent Tuberculosis Infection
por: Rodríguez, Jimmy E., et al.
Publicado: (2013)

Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection
por: Mehaffy, Carolina, et al.
Publicado: (2020)

Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection
por: Peng, Zhangli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06u69jbembnc2rhcuotq2i394j